Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.12% inched 0.29% higher to $169.98 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.16% rising 0.20% to 4,367.48 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.18% rising 0.07% to 34,823.35. This was the stock's third consecutive day of gains. Johnson & Johnson closed $3.67 short of its 52-week high ($173.65), which the company achieved on January 26th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF +0.43% fell 3.10% to $374.52, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK -1.15% rose 0.18% to $76.53, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -0.67% rose 1.10% to $41.47. Trading volume (5.2 M) remained 1.4 million below its 50-day average volume of 6.6 M.